Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
Total Valuation
Treace Medical Concepts has a market cap or net worth of $364.22M. The enterprise value is $417.70M.
Market Cap$364.22M
Enterprise Value$417.70M
Share Statistics
Treace Medical Concepts has 62,904,953 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding62,904,953
Owned by Insiders30.47%
Owned by Institutions0.09%
Financial Efficiency
Treace Medical Concepts’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -30.50%.
Return on Equity (ROE)-0.49
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-30.50%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee438.90K
Profits Per Employee-116.86K
Employee Count477
Asset Turnover0.96
Inventory Turnover1.05
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio3.44
Price to Fair Value4.09
Price to FCF-9.86
Price to Operating Cash Flow-14.09
PEG Ratio-1.23
Income Statement
In the last 12 months, Treace Medical Concepts had revenue of 209.36M and earned -55.74M in profits. Earnings per share was -0.90.
Revenue209.36M
Gross Profit168.26M
Operating Income-55.69M
Pretax Income-55.74M
Net Income-55.74M
EBITDA-42.07M
Earnings Per Share (EPS)-0.90
Cash Flow
In the last 12 months, operating cash flow was -25.75M and capital expenditures -11.21M, giving a free cash flow of -36.96M billion.
Operating Cash Flow-25.75M
Free Cash Flow-36.96M
Free Cash Flow per Share-0.59
Dividends & Yields
Treace Medical Concepts pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.93
52-Week Price Change-26.17%
50-Day Moving Average5.97
200-Day Moving Average7.29
Relative Strength Index (RSI)43.82
Average Volume (3m)287.59K
Important Dates
Treace Medical Concepts upcoming earnings date is Aug 7, 2025, After Close (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Treace Medical Concepts as a current ratio of 4.62, with Debt / Equity ratio of 65.85%
Current Ratio4.62
Quick Ratio3.50
Debt to Market Cap0.12
Net Debt to EBITDA-1.39
Interest Coverage Ratio-10.60
Taxes
In the past 12 months, Treace Medical Concepts has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Treace Medical Concepts EV to EBITDA ratio is -12.37, with an EV/FCF ratio of -10.67.
EV to Sales2.49
EV to EBITDA-12.37
EV to Free Cash Flow-10.67
EV to Operating Cash Flow-14.00
Balance Sheet
Treace Medical Concepts has $76.09M in cash and marketable securities with $69.36M in debt, giving a net cash position of -$6.72M billion.
Cash & Marketable Securities$76.09M
Total Debt$69.36M
Net Cash-$6.72M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$1.48
Margins
Gross margin is 80.25%, with operating margin of -26.60%, and net profit margin of -26.63%.
Gross Margin80.25%
Operating Margin-26.60%
Pretax Margin-26.63%
Net Profit Margin-26.63%
EBITDA Margin-20.09%
EBIT Margin-24.12%
Analyst Forecast
The average price target for Treace Medical Concepts is $10.35, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.35
Price Target Upside81.58% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast7.54%
EPS Growth Forecast4.28%